Transactions

We have a long history of advising transformative companies on their most important transactions.

circular graphic

Explore our long standing track record with
innovative growth companies

has entered into a strategic licensing agreement with
pH Partners served as the Exclusive Financial Advisor to Celularity
  • Healthcare
  • 13M*
  • Strategic Partnering
has been acquired by
a portfolio company of
pH Partners served as the Exclusive Financial Advisor to Pharmgrade
  • Agriculture
  • Undisclosed
  • Sell-Side Advisory
has formed a strategic partnership with
pH Partners served as the Exclusive Financial Advisor to SemiconBio
  • BioTech
  • Undisclosed
  • Strategic Partnering
has made an equity investment in
pH Partners served as the Exclusive Financial Advisor to CollectiveCare Dental
  • Healthcare
  • Undisclosed
  • Capital Raise
has raised Series C and Series D growth capital from
pH Partners served as the Financial Advisor to ZincFive
  • Middle Market
  • Undisclosed
  • Capital Raise
has been acquired by
pH Partners served as the Exclusive Financial Advisor to Verustat
  • Digital Health
  • Undisclosed
  • Sell-Side Advisory
has been acquired by
pH Partners served as the Exclusive Financial Advisor to Lynch Biologics
  • Regenerative Medicine
  • Undisclosed
  • Sell-Side Advisory
has been acquired by
$400M*
pH Partners served as the Exclusive Financial Advisor to Volumetric
  • Medical Device
  • $400M*
  • Sell-Side Advisory
a U.S. subsidiary of
has been acquired by
pH Partners served as the Exclusive Financial Advisor to Medi-Lynx
  • Medical Device
  • Undisclosed
  • Sell-Side Advisory
received an equity investment from
$10M
pH Partners served as the Exclusive Financial Advisor to Reliant ID
  • Tools, Diagnostics & Labs
  • 10M
  • Capital Raise
$12.8MM Series B Investment led by
$12.8M
pH Partners served as the Exclusive Financial Advisor to Saranas
  • Medical Device
  • $12.8M
  • Capital Raise
has been acquired by
pH Partners served as the Exclusive Financial Advisor to FIGmd
  • Digital Health
  • Undisclosed
  • Sell-Side Advisory
has completed a multi-target strategic R&D partnership with
pH Partners served as the Exclusive Financial Advisor to Entos
  • Therapeutics
  • Undisclosed
  • Strategic Partnering
has been acquired by
THE DIGITAL STRONGHOLD
a consortium of men's brands
comprised of
pH Partners served as the Exclusive Financial Advisor to Digital Stronghold
  • Consumer
  • Undisclosed
  • Buy-Side Advisory
has received a majority investment from
pH Partners served as the Exclusive Financial Advisor to Taylor Stitch
  • Consumer
  • Undisclosed
  • Capital Raise
has acquired
pH Partners served as the Exclusive Financial Advisor to OncoCyte
  • Tools, Diagnostics & Labs
  • Undisclosed
  • Buy-Side Advisory
has acquired
pH Partners served as the Exclusive Financial Advisor to FemTec Health
  • Digital Health
  • Undisclosed
  • Buy-Side Advisory
has made an equity investment in
pH Partners served as the Exclusive Financial Advisor to CareFirst
  • Digital Health
  • $26M
  • Capital Raise
has acquired Thermi, a wholly-owned subsidiary of Almirall
pH Partners served as the Exclusive Financial Advisor to Celling Biosciences
  • Medical Device
  • Undisclosed
  • Buy-Side Advisory
has extended their distribution agreement with and received a follow-on investment from
pH Partners served as the Exclusive Financial Advisor to OmniSeq
  • Tools, Diagnostics & Labs
  • Undisclosed
  • Strategic Partnering
has been acquired by
a portfolio company of
pH Partners served as the Exclusive Financial Advisor to One Smooth Stone
  • Business Services
  • Undisclosed
  • Sell-Side Advisory
has raised growth capital from
$80M
pH Partners served as the Exclusive Financial Advisor to VillageMD
  • Providers
  • $80M
  • Capital Raise
has made an equity investment in
pH Partners served as the Exclusive Financial Advisor to CareFirst
  • Digital Health
  • Undisclosed
  • Capital Raise
has formed a strategic relationship with
pH Partners served as the Exclusive Financial Advisor to MolecularMatch
  • Digital Health
  • Undisclosed
  • Strategic Partnering
has been acquired by
pH Partners served as the Exclusive Financial Advisor to Seed
  • Technology
  • Undisclosed
  • Sell-Side Advisory
Past performance is not a guarantee of future results. Actual results will vary and may be more or less favorable.
HomeServicesSectorsTeamContact

(512) 646-2335 | info@phpartners.com | Securities offered through pH Partners, LLC, Member FINRA/SIPC. FINRA BrokerCheck. Client Relationship Summary (Form CRS).

PRIVATE PLACEMENTS ARE HIGH RISK AND ILLIQUID INVESTMENTS. AS WITH OTHER INVESTMENTS, YOU CAN LOSE SOME OR ALL OF YOUR INVESTMENT.

The information contained herein is for informational purposes only and is not intended for further distribution. The information does not constitute a complete description of any investment or investment performance, and does not constitute an offer to buy or sell, or a solicitation of an offer to buy or sell, any security or investment product.
This site is published for residents of the United States only. Representatives may only conduct business with residents of the states and jurisdictions in which they are properly registered. Therefore, a response to a request for information may be delayed until appropriate registration is obtained or exemption from registration is determined. Not all of services referenced on this site are available in every state and through every advisor listed. For additional information, please contact us by phone at 512.646.2335 or by email at info@phpartners.com.

©2026 pH Partners. All rights reserved. Privacy PolicyTerms of Service
BrokerCheck linklinkedin logo